SCE

SCE München 48.1538958 Heßstraße 89 +498912653200

- - - - -

Short facts

Industry

Med Tech

Claim

3-D Cellanalysis: Fast. Precise. Personalized.

Support program

SCE Incubation incl. Startup Certificate (Start: March 2025) + EXIST-Women

Quote

At Cancelight, we're enabling real-time, personalized drug testing to help select the right treatment for cancer patients faster, accelerating the development of targeted therapies with precision.
- Katharina Sahiri, CEO

Cancelight

About

At Cancelight, the personalized medicine system helps pharmaceutical companies, clinicians and oncologists who experience slow and imprecise tumor characterization to reduce inefficiencies in drug development and increase the precision of new cancer therapies through faster, more accurate tissue profiling for personalized cancer treatment.

Supported by